historymanagementboard of directors investors

press releasespress coverageelectronic press kit

media

 

ABOUT LUX

Lux Biosciences is a clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. With a Phase 3 clinical trial in noninfectious uveitis ongoing, and several exciting earlier-stage projects, Lux is building a revenue-generating, high-growth, and sustainable ophthalmic company.
 

   
  © 2012 Lux Biosciences, Inc. All rights reserved. Web Terms Enlarged Text
   

 

LUVENIQ™LX214LX212proprietary technologiespipeline

uveitisdry eye syndrome

indicationstechnologies

aboutophthalmicproducts &partnersnews &careerscontact us